Browsing by Subject "bisphosphonate"
Now showing items 1-4 of 4
-
Considerações sobre o uso dos bisfosfonatos intravenosos no tratamento da osteogenese imperfeita
(Universidade Federal de São Paulo (UNIFESP), 2016-03-30)Osteogenesis imperfecta (OI) is a heritable connective tissue disorder that is mainly characterized by bone fragility, low bone mass and bone deformities. The intravenous bisphosphonate therapy, particularly the pamidronate, ...
-
Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia
(Karger, 1998-08-01)Osteopenia is frequently found among calcium stone forming (CSF) patients with hypercalciuria. We investigated the effect of a 2-year therapeutic course of etidronate, a bone-sparing agent, in 7 young male CSF patients. ...
-
Osteogenesis imperfecta: diagnosis and treatment
(Lippincott Williams & Wilkins, 2017)Purpose of reviewHere we summarize the diagnosis of osteogenesis imperfecta, discuss newly discovered genes involved in osteogenesis imperfecta, and review the management of this disease in children and adults.Recent ...
-
Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation
(Freund Publishing House Ltd, 2008-08-01)Osteoporosis-pseudoglioma (OPPG) is a rare syndrome characterized by severe osteoporosis and ocular defects caused by homozygotic inactivation mutations in the LRP5 gene. Bisphosphonate has been demonstrated to improve ...
